Picton Mahoney Asset Management Adma Biologics, Inc. Transaction History
Picton Mahoney Asset Management
- $4.9 Billion
- Q4 2024
A detailed history of Picton Mahoney Asset Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Picton Mahoney Asset Management holds 64 shares of ADMA stock, worth $1,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64Holding current value
$1,296% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
341Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$378 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$369 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$301 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$229 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$112 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.98B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...